Isolation, Characterization, and Genome Engineering of a Lytic Pseudomonas aeruginosa Phage
Open Access
- 16 November 2024
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 12 (11) , 2346
Abstract
Antibiotic-resistant bacterial infections have become one of the leading causes of human mortality. Bacteriophages presented great potential for combating antibiotic-resistant infections in the post-antibiotic era due to their high host specificity and safety profile. Pseudomonas aeruginosa, an opportunistic pathogenic bacterium, has shown a surge in multidrug-resistant strains, severely impacting both human health and livestock. In this study, we successfully isolated and purified a P. aeruginosa-specific phage, PpY1, from feces collected from a breeding farm. This phage harbors a short tail and a 43,787 bp linear genome, and exhibited potent lytic activity against several pathogenic P. aeruginosa strains. Leveraging Transformation-associated recombination (TAR) cloning and phage assembly techniques in a P. aeruginosa host lacking a restriction–modification system, we developed a genome engineering platform for PpY1. Through a systematic gene knockout approach, we identified and eliminated 21 nonessential genes from the PpY1 genome, resulting in a series of phages with reduced genomes. This research not only enhances our understanding of the phage genome but also paves the way for the functional optimization of phages, e.g., broadening the host spectrum and elevating the lytic capacity, dedicated towards the treatment of bacterial infections.Keywords
Funding Information
- National Key Research and Development Program of China (2019YFA0904003, ZR2023ZD29, tsqn201909049)
- Major Basic Research Project of Natural Science Foundation of Shandong Province (2019YFA0904003, ZR2023ZD29, tsqn201909049)
- Taishan Scholars Program of Shandong Province (2019YFA0904003, ZR2023ZD29, tsqn201909049)
This publication has 53 references indexed in Scilit:
- Antibacterial agents in preclinical and clinical developmentThe Lancet Microbe, 2024
- Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case seriesMed, 2023
- Phage engineering for development of diagnostic tools2023
- The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An UpdateDrugs, 2021
- Enhancing phage therapy through synthetic biology and genome engineeringCurrent Opinion in Biotechnology, 2021
- Single-Stranded DNA-Binding Protein and Exogenous RecBCD Inhibitors Enhance Phage-Derived Homologous Recombination in PseudomonasiScience, 2019
- Bacteriophages and its applications: an overviewFolia Microbiologica, 2016
- Engineering Modular Viral Scaffolds for Targeted Bacterial Population EditingCell Systems, 2015
- Characterization of lytic Pseudomonas aeruginosa bacteriophages via biological properties and genomic sequencesApplied Microbiology and Biotechnology, 2012
- Isolation and Characterization of Bacteriophages Infecting Staphylococcus epidermidisCurrent Microbiology, 2010